Literature DB >> 27746889

Endless Resistance. Endless Antibiotics?

Jed F Fisher1, Shahriar Mobashery1.   

Abstract

The practice of medicine was profoundly transformed by the introduction of the antibiotics (compounds isolated from Nature) and the antibacterials (compounds prepared by synthesis) for the control of bacterial infection. As a result of the extraordinary success of these compounds over decades of time, a timeless biological activity for these compounds has been presumed. This presumption is no longer. The inexorable acquisition of resistance mechanisms by bacteria is retransforming medical practice. Credible answers to this dilemma are far better recognized than they are being implemented. In this perspective we examine (and in key respects, reiterate) the chemical and biological strategies being used to address the challenge of bacterial resistance.

Entities:  

Year:  2015        PMID: 27746889      PMCID: PMC5060946          DOI: 10.1039/C5MD00394F

Source DB:  PubMed          Journal:  Medchemcomm        ISSN: 2040-2503            Impact factor:   3.597


  305 in total

Review 1.  Structure-based design of anti-infectives.

Authors:  Anil K Agarwal; Colin W G Fishwick
Journal:  Ann N Y Acad Sci       Date:  2010-12       Impact factor: 5.691

2.  Urgent need for β-lactam-β-lactamase inhibitors.

Authors:  Jung Hun Lee; Jae Jin Lee; Kwang Seung Park; Sang Hee Lee
Journal:  Lancet Infect Dis       Date:  2015-07-19       Impact factor: 25.071

3.  Antibiotic resistance genes in the environment: prioritizing risks.

Authors:  Johan Bengtsson-Palme; D G Joakim Larsson
Journal:  Nat Rev Microbiol       Date:  2015-04-27       Impact factor: 60.633

4.  Avibactam and inhibitor-resistant SHV β-lactamases.

Authors:  Marisa L Winkler; Krisztina M Papp-Wallace; Magdalena A Taracila; Robert A Bonomo
Journal:  Antimicrob Agents Chemother       Date:  2015-02-17       Impact factor: 5.191

Review 5.  Fate and effects of veterinary antibiotics in soil.

Authors:  Sven Jechalke; Holger Heuer; Jan Siemens; Wulf Amelung; Kornelia Smalla
Journal:  Trends Microbiol       Date:  2014-06-17       Impact factor: 17.079

Review 6.  The art of antibacterial warfare: Deception through interference with quorum sensing-mediated communication.

Authors:  Giordano Rampioni; Livia Leoni; Paul Williams
Journal:  Bioorg Chem       Date:  2014-04-21       Impact factor: 5.275

7.  What's in a name? The semantics of quorum sensing.

Authors:  Thomas G Platt; Clay Fuqua
Journal:  Trends Microbiol       Date:  2010-06-21       Impact factor: 17.079

8.  OP0595, a new diazabicyclooctane: mode of action as a serine β-lactamase inhibitor, antibiotic and β-lactam 'enhancer'.

Authors:  Akihiro Morinaka; Yuko Tsutsumi; Mototsugu Yamada; Kenji Suzuki; Takashi Watanabe; Takao Abe; Takeshi Furuuchi; Seiichi Inamura; Yoshiaki Sakamaki; Nakako Mitsuhashi; Takashi Ida; David M Livermore
Journal:  J Antimicrob Chemother       Date:  2015-06-18       Impact factor: 5.790

9.  Disruption of allosteric response as an unprecedented mechanism of resistance to antibiotics.

Authors:  Jennifer Fishovitz; Alzoray Rojas-Altuve; Lisandro H Otero; Matthew Dawley; Cesar Carrasco-López; Mayland Chang; Juan A Hermoso; Shahriar Mobashery
Journal:  J Am Chem Soc       Date:  2014-07-02       Impact factor: 15.419

10.  Seawater is a reservoir of multi-resistant Escherichia coli, including strains hosting plasmid-mediated quinolones resistance and extended-spectrum beta-lactamases genes.

Authors:  Marta S Alves; Anabela Pereira; Susana M Araújo; Bruno B Castro; António C M Correia; Isabel Henriques
Journal:  Front Microbiol       Date:  2014-08-20       Impact factor: 5.640

View more
  14 in total

1.  Effects of the 1- N-(4-Amino-2 S-hydroxybutyryl) and 6'- N-(2-Hydroxyethyl) Substituents on Ribosomal Selectivity, Cochleotoxicity, and Antibacterial Activity in the Sisomicin Class of Aminoglycoside Antibiotics.

Authors:  Amr Sonousi; Vikram A Sarpe; Margarita Brilkova; Jochen Schacht; Andrea Vasella; Erik C Böttger; David Crich
Journal:  ACS Infect Dis       Date:  2018-05-10       Impact factor: 5.084

2.  Understanding drug resistance will improve the treatment of bacterial infections.

Authors:  Laura J V Piddock
Journal:  Nat Rev Microbiol       Date:  2017-10-12       Impact factor: 60.633

3.  Norbornane-based cationic antimicrobial peptidomimetics targeting the bacterial membrane.

Authors:  Shane M Hickey; Trent D Ashton; Gareth Boer; Christie A Bader; Michael Thomas; Alysha G Elliott; Carsten Schmuck; Heidi Y Yu; Jian Li; Roger L Nation; Matthew A Cooper; Sally E Plush; Douglas A Brooks; Frederick M Pfeffer
Journal:  Eur J Med Chem       Date:  2018-10-03       Impact factor: 6.514

Review 4.  Constructing and deconstructing the bacterial cell wall.

Authors:  Jed F Fisher; Shahriar Mobashery
Journal:  Protein Sci       Date:  2019-11-20       Impact factor: 6.725

5.  Antibacterial Discovery via Phenotypic DNA-Encoded Library Screening.

Authors:  Wesley G Cochrane; Patrick R Fitzgerald; Brian M Paegel
Journal:  ACS Chem Biol       Date:  2021-11-20       Impact factor: 5.100

6.  Progress towards a stable cephalosporin-halogenated phenazine conjugate for antibacterial prodrug applications.

Authors:  Tao Xiao; Ke Liu; Robert W Huigens
Journal:  Bioorg Med Chem Lett       Date:  2020-08-27       Impact factor: 2.823

7.  Design, synthesis and biological evaluation of a halogenated phenazine-erythromycin conjugate prodrug for antibacterial applications.

Authors:  Hongfen Yang; Ke Liu; Shouguang Jin; Robert W Huigens Iii
Journal:  Org Biomol Chem       Date:  2021-02-25       Impact factor: 3.876

Review 8.  Brief Overview of Approaches and Challenges in New Antibiotic Development: A Focus On Drug Repurposing.

Authors:  Natalie K Boyd; Chengwen Teng; Christopher R Frei
Journal:  Front Cell Infect Microbiol       Date:  2021-05-17       Impact factor: 5.293

9.  Total Syntheses of Bulgecins A, B, and C and Their Bactericidal Potentiation of the β-Lactam Antibiotics.

Authors:  Shusuke Tomoshige; David A Dik; Masaaki Akabane-Nakata; Chinedu S Madukoma; Jed F Fisher; Joshua D Shrout; Shahriar Mobashery
Journal:  ACS Infect Dis       Date:  2018-05-07       Impact factor: 5.084

Review 10.  The Road from Host-Defense Peptides to a New Generation of Antimicrobial Drugs.

Authors:  Alicia Boto; Jose Manuel Pérez de la Lastra; Concepción C González
Journal:  Molecules       Date:  2018-02-01       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.